Search - tctmd.com

Displaying 921 - 940 of 1258

Sort: Relevancy | Date

Podcast

DAPT STEMI, MITRAL, Gender Disparities in Trial Design, and More

January 16, 2019

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Vote

News Daily News

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

Caitlin E. Cox

January 11, 2019

News Daily News

Irrational Exuberance or Evidence-Based Medicine: What Role for CT Angiography in Stable Chest Pain?

Michael O'Riordan

January 11, 2019

News Daily News

None of the Usual Suspects? Troponin Elevation Still Warrants Attention

Shelley Wood

January 11, 2019

News Opinion Fellow Talk

Early CHIP-Trained Fellow in the United States Offers Insights: Sanjog Kalra, MD

Luai Tabaza, MD

January 10, 2019

News Daily News

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

L.A. McKeown

January 10, 2019

News Daily News

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Caitlin E. Cox

January 10, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2018

Caitlin E. Cox

January 01, 2019

News Daily News

The Biggest News of 2018: TCTMD’s Top 10

Shelley Wood

December 31, 2018

News Features

Year in Review: Physicians Pick the Biggest News of 2018

TCTMD News Team

December 29, 2018

News Features

Top News in Endovascular Therapy: 2018

L.A. McKeown

December 28, 2018

News Features

Top News in Prevention: 2018

Michael O'Riordan

December 28, 2018

News Daily News

Need to Spin a Negative Trial? Consult the Playbook

Todd Neale

December 20, 2018

News Daily News

European Regulators Strike Secondary Prevention Claim for Omega-3 Drugs

Shelley Wood

December 18, 2018

News Daily News

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

L.A. McKeown

December 17, 2018

News Conference News WCC 2018

Is It Time to Loosen Restrictions on Saturated Fats and Salt?

Todd Neale

December 14, 2018

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Daily News

NOACs Significantly Curb Risk of VTE in Cancer Patients

L.A. McKeown

December 06, 2018

News Daily News

Current or Prior Cancers Affect PCI Outcomes Differently, Large Analysis Shows

L.A. McKeown

December 04, 2018

Advertisement

DAPT STEMI, MITRAL, Gender Disparities in Trial Design, and More

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

Irrational Exuberance or Evidence-Based Medicine: What Role for CT Angiography in Stable Chest Pain?

None of the Usual Suspects? Troponin Elevation Still Warrants Attention

Early CHIP-Trained Fellow in the United States Offers Insights: Sanjog Kalra, MD

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

TCTMD’s Top 10 Most Popular Stories for December 2018

The Biggest News of 2018: TCTMD’s Top 10

Year in Review: Physicians Pick the Biggest News of 2018

Top News in Endovascular Therapy: 2018

Top News in Prevention: 2018

Need to Spin a Negative Trial? Consult the Playbook

European Regulators Strike Secondary Prevention Claim for Omega-3 Drugs

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

Is It Time to Loosen Restrictions on Saturated Fats and Salt?

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

NOACs Significantly Curb Risk of VTE in Cancer Patients

Current or Prior Cancers Affect PCI Outcomes Differently, Large Analysis Shows

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content